386 related articles for article (PubMed ID: 19049844)
61. Haemostatic risk factors for cardiovascular diseases.
Koenig W
Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
[TBL] [Abstract][Full Text] [Related]
62. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
63. Fibrinolytic Changes in Women with Preeclampsia.
Godtfredsen AC; Sidelmann JJ; Dolleris BB; Jørgensen JS; Johansen EKJ; Pedersen MFB; Palarasah Y; Gram JB
Clin Appl Thromb Hemost; 2022; 28():10760296221126172. PubMed ID: 36217728
[TBL] [Abstract][Full Text] [Related]
64. Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia.
Portelinha A; Belo L; Tejera E; Rebelo I
Acta Obstet Gynecol Scand; 2008; 87(9):969-71. PubMed ID: 18720045
[TBL] [Abstract][Full Text] [Related]
65. Adiponectin is an independent predictor of tissue plasminogen activator levels in patients under haemodialysis.
do Sameiro Faria M; Ribeiro S; Nascimento H; Rocha-Pereira P; Miranda V; Mendonça D; Quintanilha A; Costa E; Belo L; Santos-Silva A
Scand J Urol Nephrol; 2012 Dec; 46(6):461-5. PubMed ID: 22852746
[TBL] [Abstract][Full Text] [Related]
66. White coat hypertension and haemostatic/fibrinolytic balance disorders.
Makris T; Stavroulakis G; Papadopoulos D; Paizis I; Krespi P; Tsoukala C; Hatzizacharias A; Votteas V
Eur Cytokine Netw; 2006 Jun; 17(2):137-41. PubMed ID: 16840033
[TBL] [Abstract][Full Text] [Related]
67. [Pre- and postpartum hemostatic characteristics in pregnancy-related hypertension and pre-eclampsia in comparison with normotensive pregnancies].
Hofmann M; Casper F; Prellwitz W; Brockerhoff P
Z Geburtshilfe Neonatol; 1996; 200(3):104-8. PubMed ID: 8963881
[TBL] [Abstract][Full Text] [Related]
68. Influence of smoking during pregnancy on haemostasis in healthy full term neonates.
Mitsiakos G; Giougi E; Papaioannou G; Karagianni P; Papadakis E; Nikolaidis N
Thromb Res; 2009; 123(3):476-81. PubMed ID: 18417192
[TBL] [Abstract][Full Text] [Related]
69. Elevated tissue plasminogen activator as a potential marker of endothelial dysfunction in pre-eclampsia: correlation with proteinuria.
Belo L; Santos-Silva A; Rumley A; Lowe G; Pereira-Leite L; Quintanilha A; Rebelo I
BJOG; 2002 Nov; 109(11):1250-5. PubMed ID: 12452463
[TBL] [Abstract][Full Text] [Related]
70. Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children.
Eisses MJ; Chandler WL
J Cardiothorac Vasc Anesth; 2008 Feb; 22(1):53-9. PubMed ID: 18249331
[TBL] [Abstract][Full Text] [Related]
71. Periodontitis is characterized by elevated PAI-1 activity.
Bizzarro S; van der Velden U; ten Heggeler JM; Leivadaros E; Hoek FJ; Gerdes VE; Bakker SJ; Gans RO; Ten Cate H; Loos BG
J Clin Periodontol; 2007 Jul; 34(7):574-80. PubMed ID: 17535288
[TBL] [Abstract][Full Text] [Related]
72. A population-based study in Ghana to investigate inter-individual variation in plasma t-PA and PAI-1.
Williams SM; Stocki S; Jiang L; Brew K; Gordon S; Vaughan DE; Brown NJ; Poku KA; Moore JH
Ethn Dis; 2007; 17(3):492-7. PubMed ID: 17985503
[TBL] [Abstract][Full Text] [Related]
73. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia].
López-Ramírez Y; Carvajal Z; Arocha-Piñango CL
Invest Clin; 2006 Sep; 47(3):233-40. PubMed ID: 17672283
[TBL] [Abstract][Full Text] [Related]
74. Haemostatic factors and intraluminal thrombus thickness in abdominal aortic aneurysm. Is secondary fibrinolysis relevant?
Siennicka A; Drozdzynska M; Chelstowski K; Cnotliwy M; Jastrzebska M
J Physiol Pharmacol; 2013 Jun; 64(3):321-30. PubMed ID: 23959729
[TBL] [Abstract][Full Text] [Related]
75. APC resistance and other haemostatic variables during pregnancy and puerperium.
Kjellberg U; Andersson NE; Rosén S; Tengborn L; Hellgren M
Thromb Haemost; 1999 Apr; 81(4):527-31. PubMed ID: 10235433
[TBL] [Abstract][Full Text] [Related]
76. Thrombotic biomarkers and left ventricle characteristics as short-term predictors of thrombotic events in patients hospitalized for acute decompensated heart failure.
Aispuru GR; Clavier MM; Cardone AJ; Gilberto DO; Barousse AP
Eur J Intern Med; 2012 Sep; 23(6):545-51. PubMed ID: 22863433
[TBL] [Abstract][Full Text] [Related]
77. Levothyroxine (LT4) suppression treatment for benign thyroid nodules alters coagulation.
Demir T; Akinci B; Comlekci A; Karaoglu O; Ozcan MA; Yener S; Yuksel F; Secil M; Yesil S
Clin Endocrinol (Oxf); 2009 Sep; 71(3):446-50. PubMed ID: 19138314
[TBL] [Abstract][Full Text] [Related]
78. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
McBane RD; Hardison RM; Sobel BE;
Am J Cardiol; 2010 Jan; 105(1):17-24. PubMed ID: 20102884
[TBL] [Abstract][Full Text] [Related]
79. Relationship between overnight neuroendocrine activity and morning haemostasis in working men.
von Känel R; Kudielka BM; Abd-el-Razik A; Gander ML; Frey K; Fischer JE
Clin Sci (Lond); 2004 Jul; 107(1):89-95. PubMed ID: 15027894
[TBL] [Abstract][Full Text] [Related]
80. Relation of cardiorespiratory fitness to inflammatory markers, fibrinolytic factors, and lipoprotein(a) in patients with type 2 diabetes mellitus.
Jae SY; Heffernan KS; Lee MK; Fernhall B; Park WH
Am J Cardiol; 2008 Sep; 102(6):700-3. PubMed ID: 18773991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
